{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:54:45Z","timestamp":1794970485656,"version":"4.9.1"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.psychres.2024.115886","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:32:43Z","timestamp":1711636363000},"page":"115886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"335","author":[{"given":"Yuan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8489-5686","authenticated-orcid":false,"given":"Shi-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Qi","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-555X","authenticated-orcid":false,"given":"Thomas R","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ping","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8381-4071","authenticated-orcid":false,"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11010014","article-title":"A conformation variant of p53 combined with machine learning identifies alzheimer disease in preclinical and prodromal stages","volume":"11","author":"Abate","year":"2020","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.psychres.2024.115886_bib0002","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","volume":"376","author":"Abbar","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2024.115886_bib0003","series-title":"The Role of Self-Compassion in Psilocybin-Assisted Motivational Enhancement Therapy to Treat Alcohol Dependence: A randomized Controlled Trial","author":"Agin-Liebes","year":"2021"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02791072.2022.2053004","article-title":"Ayahuasca ritual, personality and sociality. observational research conducted in a substance use disorder rehabilitation center in uruguay","volume":"55","author":"Apud","year":"2023","journal-title":"J. Psychoact. Drugs"},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0007","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S2213-8587(23)00120-1","article-title":"Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial","volume":"11","author":"Atila","year":"2023","journal-title":"Lancet Diabetes Endo"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0008","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/0269881115626348","article-title":"Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting","volume":"30","author":"Baggott","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0009","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1192\/bjo.2022.565","article-title":"Effects of psilocybin versus escitalopram on rumination and thought suppression in depression","volume":"8","author":"Barba","year":"2022","journal-title":"BJPsych Open"},{"key":"10.1016\/j.psychres.2024.115886_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/02791072.2021.1957183","article-title":"Psychedelic knowledge and opinions in psychiatrists at two professional conferences: an exploratory survey","volume":"54","author":"Barnett","year":"2022","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02791072.2019.1580805","article-title":"Perceived benefits of MDMA-assisted psychotherapy beyond symptom reduction: qualitative follow-up study of a clinical trial for individuals with treatment-resistant PTSD","volume":"51","author":"Barone","year":"2019","journal-title":"J. Psychoact. Drugs"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0013","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2024.115886_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114212","article-title":"Relationships between reduction in symptoms and restoration of function and wellbeing: outcomes of the Oral Ketamine Trial on Suicidality (OKTOS)","volume":"305","author":"Beaudequin","year":"2021","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/cpt.2487","article-title":"Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects","volume":"111","author":"Becker","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.psychres.2024.115886_bib0016","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.biopsych.2010.08.003","article-title":"Is Ecstasy an \"Empathogen\"? Effects of +\/- 3,4-Methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others","volume":"68","author":"Bedi","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0017","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","article-title":"Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers","volume":"86","author":"Bershad","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0018","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0019","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00213-009-1767-1","article-title":"Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss","volume":"209","author":"Bosker","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005053-197002000-00003","article-title":"Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism","volume":"150","author":"Bowen","year":"1970","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2024.115886_bib0022","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpsychires.2022.03.008","article-title":"MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD","volume":"149","author":"Brewerton","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2024.115886_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114824","article-title":"Current and future directions of drug delivery for the treatment of mental illnesses","volume":"197","author":"Brewster","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"Pt 1","key":"10.1016\/j.psychres.2024.115886_bib0024","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-017-4769-4","article-title":"Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences","volume":"235","author":"Carbonaro","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"issue":"15","key":"10.1016\/j.psychres.2024.115886_bib0026","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0027","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0028","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"17","key":"10.1016\/j.psychres.2024.115886_bib0029","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psychres.2024.115886_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.939302","article-title":"MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder","volume":"13","author":"Christie","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2024.115886_bib0031","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0032","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D'Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0033","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","article-title":"Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study","volume":"235","author":"Danforth","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0034","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0036","doi-asserted-by":"crossref","first-page":"e13143","DOI":"10.1111\/adb.13143","article-title":"Repeated low doses of LSD in healthy adults: a placebo-controlled, dose-response study","volume":"27","author":"de Wit","year":"2022","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0037","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-017-4650-5","article-title":"Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects","volume":"235","author":"Dolder","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0038","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/npp.2016.82","article-title":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","volume":"41","author":"Dolder","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0039","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00213-018-5085-3","article-title":"Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits","volume":"236","author":"Dominguez-Clave","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/JCP.0000000000001428","article-title":"Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial","volume":"41","author":"Dos Santos","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0041","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0042","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/npp.2017.171","article-title":"MDMA impairs both the encoding and retrieval of emotional recollections","volume":"43","author":"Doss","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115886_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.602590","article-title":"The effects of daytime psilocybin administration on sleep: implications for antidepressant action","volume":"11","author":"Dudysov\u00e1","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113612","article-title":"Serotonin 5-HT(2A), 5-HT(2c) and 5-HT(1A) receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response","volume":"154","author":"Erkizia-Santamar\u00eda","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00213-020-05710-w","article-title":"Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy","volume":"238","author":"Feduccia","year":"2021","journal-title":"Psychopharmacology (Berl.)"},{"issue":"Pt A","key":"10.1016\/j.psychres.2024.115886_bib0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0047","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0048","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0049","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/02791072.2020.1789247","article-title":"Pilot evaluation of a residential drug addiction treatment combining traditional amazonian medicine, ayahuasca and psychotherapy on depression and anxiety","volume":"52","author":"Giovannetti","year":"2020","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"NeuronNeuron"},{"issue":"18","key":"10.1016\/j.psychres.2024.115886_bib0051","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2024.115886_bib0052","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0053","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41386-023-01648-7","article-title":"Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication","volume":"48","author":"Goodwin","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0054","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jts.22479","article-title":"Posttraumatic growth after MDMA-assisted psychotherapy for posttraumatic stress disorder","volume":"33","author":"Gorman","year":"2020","journal-title":"J. Trauma Stress"},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2005-918695","article-title":"Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis","volume":"38","author":"Gouzoulis-Mayfrank","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2024.115886_bib0056","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0057","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0058","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.psychres.2024.115886_bib0059","first-page":"103","article-title":"Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations","volume":"73","author":"Grob","year":"1996","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000467984","article-title":"LSD-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof","year":"1973","journal-title":"Int. Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0061","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"522","key":"10.1016\/j.psychres.2024.115886_bib0062","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6435","article-title":"Distinct neural mechanisms for the prosocial and rewarding properties of MDMA","volume":"11","author":"Heifets","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"6633","key":"10.1016\/j.psychres.2024.115886_bib0063","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.adg2989","article-title":"Possible psychedelic therapeutic mechanism","volume":"379","author":"Hess","year":"2023","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0064","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1176\/ajp.125.10.1352","article-title":"A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetmine in alcoholics","volume":"125","author":"Hollister","year":"1969","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiat."},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0066","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115886_bib0067","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2020.10.002","article-title":"Mood and cognition after administration of low LSD doses in healthy volunteers: a placebo controlled dose-effect finding study","volume":"41","author":"Hutten","year":"2020","journal-title":"Eur. Neuropsychopharm."},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0068","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/JCP.0b013e3182979d32","article-title":"alpha(1)-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans","volume":"33","author":"Hysek","year":"2013","journal-title":"J. Clin. Psychopharm."},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0069","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/scan\/nst161","article-title":"MDMA enhances emotional empathy and prosocial behavior","volume":"9","author":"Hysek","year":"2014","journal-title":"Soc. Cogn. Affect. Neur."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1590\/1516-4446-2020-0980","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil","volume":"43","author":"Jardim","year":"2021","journal-title":"Braz. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0071","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0072","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol. Abuse."},{"key":"10.1016\/j.psychres.2024.115886_bib0073","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0074","doi-asserted-by":"crossref","first-page":"21927","DOI":"10.1038\/s41598-022-25658-5","article-title":"Associations between MDMA\/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents","volume":"12","author":"Jones","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/02698811211066714","article-title":"Lifetime use of MDMA\/ecstasy and psilocybin is associated with reduced odds of major depressive episodes","volume":"36","author":"Jones","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0076","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/appi.ajp.2020.20010057","article-title":"Novel insights into pathological anxiety and anxiety-related disorders","volume":"177","author":"Kalin","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0077","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF01575629","article-title":"Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide","volume":"41","author":"Kast","year":"1967","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.psychres.2024.115886_bib0078","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1213\/00000539-196405000-00013","article-title":"Study of lysergic acid diethylamide as an analgesic agent","volume":"43","author":"Kast","year":"1964","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.psychres.2024.115886_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.883869","article-title":"Decreases in state and trait anxiety post-psilocybin: a naturalistic, Observational study among retreat attendees","volume":"13","author":"Kiraga","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0080","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2024.115886_bib0081","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0082","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.psychres.2024.115886_bib0083","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/02698811080220081401","article-title":"Memory and mood during the night and in the morning after repeated evening doses of MDMA","volume":"22","author":"Kuypers","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0084","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41598-018-19618-1","article-title":"Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter","volume":"8","author":"Kuypers","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.psychres.2024.115886_bib0086","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/ajad.12577","article-title":"Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use","volume":"26","author":"Lev-Ran","year":"2017","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0087","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jpainsymman.2023.06.006","article-title":"HOPE: a pilot study of psilocybin enhanced group psychotherapy in patients with cancer","volume":"66","author":"Lewis","year":"2023","journal-title":"J. Pain Symptom Manage."},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0088","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","article-title":"Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') are attenuated by the serotonin uptake inhibitor citalopram","volume":"22","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0089","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0893-133X(00)00126-3","article-title":"Psychological and physiological effects of MDMA (\"Ecstasy\") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans","volume":"23","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/ajp.126.1.59","article-title":"A clinical study of LSD treatmnt in alcoholism","volume":"126","author":"Ludwig","year":"1969","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115886_bib0091","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3389\/fpsyg.2018.01721","article-title":"More realistic forecasting of future life events after psilocybin for treatment-resistant depression","volume":"9","author":"Lyons","year":"2018","journal-title":"Front. Psychol."},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0092","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.addbeh.2012.05.022","article-title":"Antidepressant-like effects of ecstasy in subjects with a predisposition to depression","volume":"37","author":"Majumder","year":"2012","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0093","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/02698811211050556","article-title":"Psilocybin microdosing does not affect emotion-related symptoms and processing: a preregistered field and lab-based study","volume":"36","author":"Marschall","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0094","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/ijms24021329","article-title":"The Bright Side of Psychedelics: latest Advances and Challenges in Neuropharmacology","volume":"24","author":"Mastinu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mcna.2022.04.003","article-title":"Post-traumatic Stress Disorder","volume":"107","author":"Merians","year":"2023","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.psychres.2024.115886_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.873455","article-title":"Music programming for psilocybin-assisted therapy: guided Imagery and Music-informed perspectives","volume":"13","author":"Messell","year":"2022","journal-title":"Front. Psychol."},{"issue":"6","key":"10.1016\/j.psychres.2024.115886_bib0097","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0098","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.psychres.2024.115886_bib0099","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"issue":"6","key":"10.1016\/j.psychres.2024.115886_bib0100","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"The Lancet Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0101","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41380-020-00878-1","article-title":"Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals","volume":"26","author":"Mkrtchian","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0102","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2024.115886_bib0103","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00213-022-06066-z","article-title":"Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants","volume":"239","author":"M\u00fcller","year":"2022","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115886_bib0104","article-title":"Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression","volume":"12","author":"Murphy","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109356","article-title":"The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD","volume":"233","author":"Nicholas","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0106","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of mdma (\u00b13,4-methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD)","volume":"27","author":"Oehen","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0107","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1017\/S1461145710001215","article-title":"Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour","volume":"14","author":"Orejarena","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0108","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fpsyt.2017.00240","article-title":"The \"Endless Trip\" among the NPS Users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A systematic review","volume":"8","author":"Orsolini","year":"2017","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"Os\u00f3rio Fde","year":"2015","journal-title":"Braz. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2024.115886_bib0110","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0269881118806297","article-title":"3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial","volume":"32","author":"Ot'alora","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0111","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2024.115886_bib0112","first-page":"144","article-title":"LSD-assisted psychotherapy with terminal cancer patients","volume":"9","author":"Pahnke","year":"1969","journal-title":"Curr. Psychiatr. Ther."},{"issue":"11","key":"10.1016\/j.psychres.2024.115886_bib0113","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1001\/jama.1970.03170240060010","article-title":"The experimental use of psychedelic (LSD) psychotherapy","volume":"212","author":"Pahnke","year":"1970","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0114","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0116","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41386-022-01324-2","article-title":"Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice","volume":"47","author":"P\u0119dzich","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"10277","key":"10.1016\/j.psychres.2024.115886_bib0117","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","article-title":"Anxiety disorders","volume":"397","author":"Penninx","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2024.115886_bib0118","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.884703","article-title":"Changes in mental health, wellbeing and personality following ayahuasca consumption: results of a naturalistic longitudinal study","volume":"13","author":"Perkins","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0119","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2014.03.008","article-title":"Memory and mood during MDMA intoxication, with and without memantine pretreatment","volume":"87","author":"Perna","year":"2014","journal-title":"NeuropharmacologyNeuropharmacology"},{"issue":"9","key":"10.1016\/j.psychres.2024.115886_bib0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ijnp\/pyx047","article-title":"Effect of psilocybin on empathy and moral decision-making","volume":"20","author":"Pokorny","year":"2017","journal-title":"Int. J. Neuropsychoph."},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0121","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/02698811231155117","article-title":"Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors","volume":"37","author":"Ponomarenko","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0122","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jts.22696","article-title":"Sleep quality improvements after mdma-assisted psychotherapy for the treatment of posttraumatic stress disorder","volume":"34","author":"Ponte","year":"2021","journal-title":"J. Trauma Stress"},{"issue":"9","key":"10.1016\/j.psychres.2024.115886_bib0123","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0124","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0269881120940937","article-title":"A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers","volume":"35","author":"Ramaekers","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1133414","article-title":"A phase 1\/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression","volume":"14","author":"Reckweg","year":"2023","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0126","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and Psychedelic-Assisted Psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiat."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00213-005-0068-6","article-title":"The 5-HT1A receptor and the stimulus effects of LSD in the rat","volume":"182","author":"Reissig","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"issue":"5","key":"10.1016\/j.psychres.2024.115886_bib0128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41582-022-00635-8","article-title":"Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits","volume":"18","author":"Ressler","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0129","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/0269881120919957","article-title":"Efficacy of psychedelic treatments on depressive symptoms: a meta-analysis","volume":"34","author":"Romeo","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/07067437221111371","article-title":"The Canadian network for mood and anxiety treatments (CANMAT) task force report: serotonergic psychedelic treatments for major depressive disorder","volume":"68","author":"Rosenblat","year":"2023","journal-title":"Can. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0132","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer","volume":"4","author":"Ross","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"12","key":"10.1016\/j.psychres.2024.115886_bib0133","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0134","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/02698811211064720","article-title":"The effects of psilocybin on cognitive and emotional functions in healthy participants: results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation","volume":"36","author":"Rucker","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0136","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jep.2007.04.012","article-title":"Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members","volume":"112","author":"Santos","year":"2007","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0137","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s13311-020-00962-y","article-title":"Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin","volume":"18","author":"Schindler","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.psychres.2024.115886_bib0138","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/head.14420","article-title":"Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: results from a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Schindler","year":"2022","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0139","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0269881120959604","article-title":"Acute subjective effects in LSD- and MDMA-assisted psychotherapy","volume":"35","author":"Schmid","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2024.115886_bib0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0269881114542454","article-title":"Differential effects of MDMA and methylphenidate on social cognition","volume":"28","author":"Schmid","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0141","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00213-017-4733-3","article-title":"Long-lasting subjective effects of LSD in normal subjects","volume":"235","author":"Schmid","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115886_bib0142","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jpsychires.2023.03.031","article-title":"Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder","volume":"161","author":"Schneier","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0143","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0269881121991792","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder","volume":"35","author":"Sessa","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0144","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230109","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants","volume":"12","author":"Sessa","year":"2019","journal-title":"BMJ Case Rep."},{"issue":"16","key":"10.1016\/j.psychres.2024.115886_bib0145","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"NeuronNeuron"},{"key":"10.1016\/j.psychres.2024.115886_bib0146","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jad.2022.11.046","article-title":"Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients","volume":"323","author":"Shnayder","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.115886_bib0147","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.947622","article-title":"Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder","volume":"13","author":"Singleton","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115886_bib0148","doi-asserted-by":"crossref","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","author":"Sloshower","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0149","doi-asserted-by":"crossref","first-page":"469","DOI":"10.15288\/qjsa.1966.27.469","article-title":"A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior","volume":"27","author":"Smart","year":"1966","journal-title":"Q. J. Stud. Alcohol"},{"key":"10.1016\/j.psychres.2024.115886_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.991753","article-title":"A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy","volume":"13","author":"Sottile","year":"2022","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0151","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/acsptsci.0c00169","article-title":"Psilocybin-assisted group therapy and attachment: observed reduction in attachment anxiety and influences of attachment insecurity on the psilocybin experience","volume":"4","author":"Stauffer","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0152","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00213-017-4754-y","article-title":"Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression","volume":"235","author":"Stroud","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0153","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/s41598-024-53363-y","article-title":"Effects of DMT on mental health outcomes in healthy volunteers","volume":"14","author":"Timmermann","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0154","doi-asserted-by":"crossref","first-page":"932","DOI":"10.15288\/qjsa.1970.31.932","article-title":"Lysergide treatment of schizophrenic and nonschizophrenic alcoholics: a controlled evaluation","volume":"31","author":"Tomsovic","year":"1970","journal-title":"Q. J. Stud. Alcohol"},{"issue":"3","key":"10.1016\/j.psychres.2024.115886_bib0155","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00213-019-05414-w","article-title":"Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment","volume":"237","author":"Uthaug","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0156","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00213-021-05817-8","article-title":"A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats","volume":"238","author":"Uthaug","year":"2021","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295926","article-title":"Effects of MDMA-assisted therapy for PTSD on self-experience","volume":"19","author":"van der Kolk","year":"2024","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.psychres.2024.115886_bib0158","doi-asserted-by":"crossref","first-page":"e40187","DOI":"10.1371\/journal.pone.0040187","article-title":"Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors","volume":"7","author":"van Wel","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.psychres.2024.115886_bib0159","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8090331","article-title":"Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials","volume":"8","author":"Vargas","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.psychres.2024.115886_bib0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0161","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41398-023-02477-4","article-title":"Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants","volume":"13","author":"Vogt","year":"2023","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.psychres.2024.115886_bib0162","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"Eclinicalmedicine"},{"issue":"8","key":"10.1016\/j.psychres.2024.115886_bib0163","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881117711712","article-title":"Therapeutic effect of increased openness: investigating mechanism of action in MDMA-assisted psychotherapy","volume":"31","author":"Wagner","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115886_bib0164","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2023.04.081","article-title":"Increased low-frequency brain responses to music after psilocybin therapy for depression","volume":"333","author":"Wall","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.115886_bib0165","doi-asserted-by":"crossref","DOI":"10.1177\/00221678211023663","article-title":"Scaling Up: multisite open-label clinical trials of MDMA-assisted therapy for severe posttraumatic stress disorder","author":"Wang","year":"2021","journal-title":"J Humanistic Psychol"},{"issue":"21","key":"10.1016\/j.psychres.2024.115886_bib0166","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1007\/s00213-014-3570-x","article-title":"MDMA alters emotional processing and facilitates positive social interaction","volume":"231","author":"Wardle","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0167","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1017\/S0033291723001514","article-title":"Personality change in a trial of psilocybin therapy v Escitalopram treatment for depression","volume":"54","author":"Weiss","year":"2023","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0168","doi-asserted-by":"crossref","first-page":"20442","DOI":"10.1038\/s41598-020-75706-1","article-title":"MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study","volume":"10","author":"Wolfson","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.psychres.2024.115886_bib0169","doi-asserted-by":"crossref","DOI":"10.1080\/20008066.2023.2297536","article-title":"Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder","volume":"15","author":"Zeifman","year":"2024","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.psychres.2024.115886_bib0170","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fphar.2019.01325","article-title":"The impact of ayahuasca on suicidality: results from a randomized controlled trial","volume":"10","author":"Zeifman","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2024.115886_bib0171","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-020-05692-9","article-title":"Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial","volume":"238","author":"Zeifman","year":"2021","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115886_bib0172","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2023.04.105","article-title":"How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change","volume":"334","author":"Zeifman","year":"2023","journal-title":"J. Affect. Disord."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124001719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124001719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T18:38:21Z","timestamp":1717871901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124001719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":172,"alternative-id":["S0165178124001719"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115886","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115886"}}